p53 targetting program(Z53 therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namep53 targetting program(Z53 therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 inhibitors
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZ53 Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZ53 Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A